Paraxanthine
Top View
- Adenosine A2A Receptor Antagonists As Novel Anti-Parkinsonian Agents: a Review of Structure-Activity Relationships
- RESPIRATORY ACTIVITY in MEDULLA OBLONGATA and Its Modulation by ADENOSINE and OPIOIDS
- Theophylline Assay Preservatives, and Stabilizers
- FEI Prohibited Substances List the 2011 List of FEI Prohibited Substances Will Come Into Effect on 4 April 2011
- Therapeutic Class Overview Short-Acting Opioids
- Comparative Pharmacokinetics of Caffeine and Its Primary Demethylated Metabolites Paraxanthine, Theobromine and Theophylline in Man
- The Possible Actions of Methylxanthines on Various Tissues
- Pharmacological Potential of Methylxanthines: Retrospective Analysis and Future Expectations
- Annual Report
- Scientific Background
- 2015 Report on Prohibited Substances
- Extract from the Clinical Evaluation Report for Armodafinil
- Caffeine Has Grown
- Array-Based Sensing of Purine Derivatives with Fluorescence Dyes
- Transient Inhibition of Astrocytogenesis in Developing Mouse Brain Following Postnatal Caffeine Exposure
- A Comprehensive Overview of Edcs and Ppcps in Water
- Maternal Caffeine Intake Has Minor Effects on Adenosine Receptor Ontogeny in the Rat Brain
- 1 510(K) SUBSTANTIAL EQUIVALENCE DETERMINATION